Kaynakça
Blanca-Lopez N, Soriano V, Garcia-Martin E, Canto G, Blanca M. NSAID-induced reactions: classification, prevalence, impact, and management strategies. J Asthma Allergy. 2019;12:217-33.
Doña I, Pérez-Sánchez N, Eguiluz-Gracia I, et al. Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Allergy. 2020;75:561-75.
Romano A, Valluzzi RL, Alvarez-Cuesta E, et al. Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: aWAO statement. World Allergy Organ J. 2025;18:101086.
Steering Committee Authors; Berges-Gimeno MP, Alvarez-Cuesta E, et al. Drug hypersensitivity reactions in children in clinical practice: a WAO Statement. World Allergy Organ J. 2025;18:101087.
Kidon MI, Kang LW, Chin CW, Hoon LS, Hugo VB. Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children. Allergy Asthma Clin Immunol. 2007;3:114-22.
Cavkaytar O, Arga M. NSAID hypersensitivity in the pediatric population: classification and diagnostic strategies. J Asthma Allergy. 2022;15:1383-99.
Yilmaz O, Ertoy Karagol IH, Bakirtas A, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy. 2013;68:1555-61.
Arikoglu T, Aslan G, Yildirim DD, Batmaz SB, Kuyucu S. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children. Allergol Int. 2017;66:418-24.
Yilmaz Topal O, Kulhas Celik I, Turgay Yagmur I, et al. Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity. Ann Allergy Asthma Immunol. 2020;125:202-7.
Podlecka D, Socha-Banasiak A, Jerzynska J, Nodzykowska J, Brzozowska A. Practical approach to hypersensitivity to nonsteroidal anti-ınflammatory drugs (NSAIDs) in children. Pharmaceuticals (Basel). 2023;16:1237.
Kidon MI, Kang LW, Chin CW, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics. 2005;116:e675-80.
Aytekin Güvenir F, Turgay Yağmur İ, Dibek Mısırlıoğlu E. Alternative drug safety in children with nonsteroidal anti-inflammatory drug hypersensitivity. Int Arch Allergy Immunol. 2024;185:921-7.
Koh YI, Yu JE, Sim DW. Cross-reactive NSAID hypersensitivity: clinical findings from aspirin provocation and alternative drug challenge testing. Clin Transl Sci. 2025;18:e70335.
Bensko JC, McGill A, Palumbo M, Cahill KN, Laidlaw TM. Pediatric-onset aspirin-exacerbated respiratory disease: clinical characteristics, prevalence, and response to dupilumab. J Allergy Clin Immunol Pract. 2022;10:2466-8.
Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2019;74:28-39.
Haque R, White AA, Jackson DJ, Hopkins C. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;148:283-91.
Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219-32.
Valluzzi RL, Urbani S, Sciannamea M, et al. Diagnosing nonsteroidal anti-inflammatory drug-hypersensitivity/allergy and nonsteroidal anti-inflammatory drug-exacerbated or induced food allergy phenotypes in children and adolescents. J Allergy Clin Immunol Pract. 2026:S2213-2198(26)00582-9.
Barbaud A, Garvey LH, Torres M, et al. EAACI/ENDA position paper on drug provocation testing. Allergy. 2024;79:565-79.
Uluc NN, Uluc NN, Iskender N, et al. Tolerance evaluation of nonsteroidal anti-inflammatory drug hypersensitivity in children: is age the crucial factor? Int Arch Allergy Immunol. 2025;186:1155-65.
